Shimadzu forms pact with Acuson

Article

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

Shimadzu officials will use the 128 XP/4 Advanced to fill aneed for a mid-tier color-flow system in its domestic productline, according to Yuji Shimizu, project leader of medical systemsmarketing at Shimadzu.

"We see this as an opportunity to expand our market share,"he said.

The alliance will enable Acuson to take advantage of Shimadzu'straditionally strong relationships with physicians in Japan'scommunity and public hospitals, said Judy Barton, Acuson's marketingmanager for Asia/Pacific and Latin American regions.

The manufacturer's Japanese subsidiary Acuson Nippon will continueto provide installation, training and service support for theXP/4 installed base, Barton said. It also spearheads Acuson'ssales of the high-performance 128 XP/10 to large hospitals anduniversity-based facilities in Japan, she said. No financial termswere disclosed.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.